Nature is moving to the top of the C-suite agenda. BCG associate director Dean Muruven sat down with Erin Billman, executive director of the Science Based Targets Network (SBTN) and Edith Martin, global biodiversity lead at Quantis (a BCG company), to discuss the opportunity for businesses to help address the crisis unfolding in the natural world.
Beyond carbon: Embedding nature risks across the pharma value chain
Why pharma must tackle its hidden dependence on nature to safeguard patients, secure supply chains and build long-term resilience.
